Investor insights
Sectors invested in
Pre-Clinical1
Therapeutics1
Drug Discovery1
Structure-Based Drug Design platform capabilities1
Gastroenterology1
Novel Medicines1
Chemistry1
Inflammatory1
GPCR1
Neurology1
Biotechnology1
Pharmaceutical1
Computational Chemistry1
Molecular Pharmacology1
Immunology1
Funding rounds participated in
$21M sweet spot round size
Most of their 1 investments are in rounds between $21M and $21M
Investor type
Private Equity Firm
Venture Capital
Basic info
Industry
international affairs
Sectors
Peacebuilding
Global Governance
Climate Change
Nuclear Security
Multilateralism
Human Protection
Date founded
1956
Investments made
S
Sosei Heptares raised $21M on June 27, 2013
Investors: Takeda UK Limited, Clarus Ventures, LLC and The Stanley Foundation